BioSpace News Archive

Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM) serving approximately 33 million members nationally, released the following statement in response to the recent enactment of " The Ensuring Innovation Act” and the " Advancing Education on Biosimilars Act of 2021 " by the U.S. Congress.

Q-State Biosciences (“Q-State”), a discovery-stage therapeutics and technology company advancing programs for the treatment of epilepsy, pain, and other disorders of the central nervous system, announced today three new appointments to its executive leadership team: Dr. Graham Dempsey, Ph.D., has been appointed to the position of Chief Scientific Officer and Head of Research and Development;

Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that the United States Patent Office (USPTO) issued U.S. Patent No. 10,981,981 with an expiry of May 2034.

Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing an integrated companion diagnostic (CDx) and therapeutic strategy for treating patients with cancer, today announced that it will release its financial results for the first quarter 2021 after the stock market close on Monday, May 10, 2021. Management will host a webcast/conference call the same day at 4:30 p.m. Eastern Time (ET) to discuss the results.

TAAG Genetics is proud to announce our expansion into the United States with the opening of a new laboratory in St. Charles, IL.

Gamma Delta T Cell Therapy Market To Witness Exponential Growth Once The Therapy Is Commercially Available In The Market Says Kuick Research

BioIVT, a leading provider of research models and services for drug and diagnostic development, will discuss how it can help clients to meet the new EU regulatory requirements for in vitro diagnostic devices during a virtual Lunch & Learn session at 11 a.m. ET on April 27.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that in response to the rapid increase in COVID-19 cases in India, the company is providing its voluntary licensing partners with technical assistance, support for the addition of new local manufacturing facilities and the donation of active pharmaceutical ingredient (API) to rapidly scale up production of remdesivir

Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report fiscal first quarter 2021 financial results after market close on Thursday, May 6, 2021.

The American Pharmacists Association and the American Society of Health-System Pharmacists hailed the introduction of bipartisan legislation in the U.S. Senate that would give tens of millions of Medicare patients in medically underserved communities access to critically needed primary health care services delivered by pharmacists.